These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 28550094

  • 1. Safety of Outpatient Initiation of Disopyramide for Obstructive Hypertrophic Cardiomyopathy Patients.
    Adler A, Fourey D, Weissler-Snir A, Hindieh W, Chan RH, Gollob MH, Rakowski H.
    J Am Heart Assoc; 2017 May 26; 6(6):. PubMed ID: 28550094
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of flecainide on left ventricular pressure gradient and symptoms in obstructive hypertrophic cardiomyopathy: a comparison of flecainide and disopyramide.
    Haruki S, Minami Y, Suzuki A, Hagiwara N.
    Heart Vessels; 2015 Sep 26; 30(5):604-10. PubMed ID: 24917414
    [Abstract] [Full Text] [Related]

  • 6. Severe respiratory failure and torsades de pointes induced by disopyramide in a patient with myasthenia gravis.
    Hirose K, Yamaguchi H, Oshima Y, Choraku M, Hirono A, Takamori N, Tamura K.
    Intern Med; 2008 Sep 26; 47(19):1703-8. PubMed ID: 18827420
    [Abstract] [Full Text] [Related]

  • 7. Effect of disopyramide on left ventricular pressure gradient in hypertrophic obstructive cardiomyopathy in comparison with propranolol--a case report.
    Tokudome T, Mizushige K, Ueda T, Sakamoto S, Matsuo H.
    Angiology; 1999 Apr 26; 50(4):331-5. PubMed ID: 10225470
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Efficacy of continuous intravenous drip infusion of disopyramide in hypertrophic obstructive cardiomyopathy during cardiogenic shock: a case report].
    Kajimoto K, Harada T, Imamura K, Matsuda N, Niki K, Hagiwara N, Kasanuki H.
    J Cardiol; 2000 Mar 26; 35(3):197-203. PubMed ID: 10808427
    [Abstract] [Full Text] [Related]

  • 10. Torsades de pointes due to drug interaction between disopyramide and clarithromycin.
    Choudhury L, Grais IM, Passman RS.
    Heart Dis; 1999 Mar 26; 1(4):206-7. PubMed ID: 11720625
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Danger of use of disopyramide in patients with hypertrophic obstructive cardiomyopathy. An electrophysiologic study.
    Miyajima S, Aizawa Y, Matsuoka A, Okabe M, Shibata A.
    Jpn Heart J; 1988 Jan 26; 29(1):115-9. PubMed ID: 3398239
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of intravenous disopyramide on coronary hemodynamics and vasodilator reserve in hypertrophic obstructive cardiomyopathy.
    Hongo M, Nakatsuka T, Takenaka H, Tanaka M, Watanabe N, Yazaki Y, Sekiguchi M.
    Cardiology; 1996 Jan 26; 87(1):6-11. PubMed ID: 8631046
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy.
    Kimball BP, Bui S, Wigle ED.
    Am Heart J; 1993 Jun 26; 125(6):1691-7. PubMed ID: 8498312
    [Abstract] [Full Text] [Related]

  • 20. [Doppler and echocardiographic assessments of effects of disopyramide on non-obstructive hypertrophic cardiomyopathy].
    Nagashima J.
    J Cardiol; 1991 Jun 26; 21(1):75-86. PubMed ID: 1817183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.